PerQdisc for Low Back Pain
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are on opioid medication, you must not exceed 60 MME (morphine milligram equivalent) per day or have any changes in your opioid prescription within 60 days of surgery.
How is the PerQdisc treatment different from other treatments for low back pain?
PerQdisc is unique because it involves the use of a hydrogel that is administered directly into the disc in the spine, which is different from typical treatments like oral medications or surgery. This approach aims to address the underlying disc issues by providing mechanical support and potentially reducing inflammation, offering a minimally invasive alternative for patients who do not respond to conventional therapies.12345
What is the purpose of this trial?
This is a traditional feasibility study (TFS) study to evaluate the safety and effectiveness of the PerQdisc. The study is prospective, multicenter, and open label.After a screening period, qualified participants will be enrolled and treated with the PerQdisc. Patients will not be blinded to their treatment. Participants will then complete the safety follow-up period.
Eligibility Criteria
This trial is for individuals experiencing back pain, specifically discogenic low back pain. Participants should be suitable candidates for the PerQdisc treatment based on a screening process. Details about specific inclusion and exclusion criteria are not provided, but typically these would outline health conditions or factors that qualify or disqualify someone from participating.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are treated with the PerQdisc device to evaluate its safety and effectiveness
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- PerQdisc
Find a Clinic Near You
Who Is Running the Clinical Trial?
Spinal Stabilization Technologies
Lead Sponsor